Markus Enzelberger und Officer Of Morphosys - Info zur Person

(1 - 22 von 33

)

DGAP-News: Markus Enzelberger, Chief Scientific Officer of

www.sharewise.com

Ağ20 Kas · DGAP-News: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure

Markus Enzelberger, Chief Scientific Officer of MorphoSys ...www.morphosys.com › news › markus-enzelberger-...

www.morphosys.com

· The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, November 20, Markus Enzelberger, Chief ...

Markus Enzelberger, Chief Scientific Officer of MorphoSys ...AP News

apnews.com

› article

MorphoSys Announces That Its Licensee Janssen Has ...morphosysus.com

www.morphosysus.com

Markus Enzelberger, Interim Chief Scientific Officer of MorphoSys AG, said: "We are very pleased that our licensee Janssen has started pivotal phase › ...

Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces...

markets.businessinsider.com

Markus Enzelberger, the company's Chief Scientific Officer (CSO), has decided to step down as CSO and member of the company's Management ...

LEO Pharma and MorphoSys Expand Strategic Alliance to Develop...

www.businesswire.com

... Pharma with the goal of developing novel, peptide-derived drugs,” said Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG.

MorphoSys to Present at Upcoming Investor Conferenceswww.1stoncology.com › blog › morphosys-to-prese...

www.1stoncology.com

· Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG. Investor & Analyst Event Date: December 5, Venue: New York, NY, U.S.

Markus Enzelberger, Chief Scientific Officer of Yahoo Financefinance.yahoo.com › news › markus-enzelberger-ch...

finance.yahoo.com

· Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure · PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 20,

Markus Enzelberger, Chief Scientific Officer of MorphoSys ...AccessWire

www.accesswire.com

› Ma...

Markus Enzelberger, Chief Scientific Officer of BioSpacewww.biospace.com › article › markus-enzelberger-c...

www.biospace.com

· Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure - read this article along with other careers information, ...

Markus Enzelberger, Chief Scientific Officer of StreetInsiderwww.streetinsider.com › Accesswire › Markus+Enze...

www.streetinsider.com

Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure. November 20, :30 PM. PLANEGG/MUNICH, GERMANY / ACCESSWIRE ...

[PDF] Markus Enzelberger, Chief Scientific Officer of MorphoSys ...n.eqs.com › fncls

n.eqs.com

· MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; Nasdaq: MOR) today announced that Dr. Markus Enzelberger, the company's Chief ...

Baystreet.ca

www.baystreet.ca

Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure. [ACCESSWIRE]. PLANEGG/MUNICH, GERMANY ...

EdgarFilingSEC.gov

www.sec.gov

... the continuation of the current clinical development of MOR106 in atopic dermatitis” said Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys. › exh_991

ACROFANus.acrofan.com › detail

us.acrofan.com

... outside of I-Mab's territories after clinical proof of concept," commented Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG.

Mesothelioma Drug Suffers Setback in Clinical MesotheliomaHelpwww.mesotheliomahelp.org › treatment › mesotheli...

www.mesotheliomahelp.org

Markus Enzelberger, Interim Chief Scientific Officer of MorphoSys AG, that partnered with Bayer in the trial, according to a July 21 press release. The main purpose ...

MorphoSys AG (Form: 6-K, Received: :07:45)

www.otcmarkets.com

Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG, said: “We are very pleased that our licensee Janssen has started a pivotal ...

MOR106 clinical development in atopic dermatitis stopped for futilitykommunikasjon.ntb.no › pressemelding › mor106-c...

kommunikasjon.ntb.no

· Markus Enzelberger, Chief Scientific Officer of MorphoSys. “While we are clearly disappointed, we remain committed to the development of ...

Plaque psoriasis drug Tremfya receives Australian & Brazilian...

www.pharmabiz.com

Dr. Markus Enzelberger, chief scientifc officer of MorphoSys AG, said: "We are very pleased about the Tremfya approvals in Brazil and Australia ...

MorphoSys' licensee Janssen receives Japanese approval for Tremfya to...

www.pharmabiz.com

Dr Markus Enzelberger, chief scientifc officer of MorphoSys AG, said: "We are very pleased about yet another Tremfya approval in such a short ...

Alle Infos zum Namen "Markus Enzelberger"

Verwandte Suchanfragen zu Markus Enzelberger

Franz Frei
Marlies Sproll
Otto Himmler

Laura Meier
Andreas Döbel
Till Bachmann

Stefanie Urlinger
Malte Peters
Johannes Kurzweil

Personen
Vorname "Markus" (61377)
Name "Enzelberger" (29)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Markus Enzelberger und Officer Of Morphosys Person-Info